Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Zimmer Receives FDA Nod To Market IASSIST Knee - Quick Facts

RELATED NEWS
Trade ZMH now with 

Zimmer Holdings, Inc. (ZMH: Quote), announced Thursday that it has received a 510(k) clearance from the U.S. Food and Drug Administration or FDA, enabling it to market iASSIST Knee, the company's personalized guidance system for knee replacement procedures.

The iASSIST Knee technology which comprises small electronic disposable pod components, provides accurate alignment validation through an electronic display, at the site of the knee replacement surgery.

The technology enables surgeons to easily perform joint replacement procedures as the iASSIST Knee technology provides accurate intraoperative feedback required for such procedures, said Zimmer in a statement.

Jeff McCaulley, President of Zimmer Reconstructive stated, "This technology supports more streamlined and personalized knee replacement procedures through a simple, disposable intraoperative device and delivers accurate implant positioning and alignment validation without the complexity, cost and time associated with current intensive navigation and robotic systems."

Click here to receive FREE breaking news email alerts for Zimmer Holdings Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Chinese authorities on Tuesday eased some rules for mortgages for buying a second home, in a bid to boost the housing market. The People's Bank of China and the China Banking Regulatory Commission said in a joint statement that buyers who already own one apartment, but have paid off the mortgage... The Reserve Bank of India kept its key rates unchanged once again as expected, citing upside risks to medium-term inflation target. The decision announced Tuesday meant that the repo rate was left unchanged at 8.00 percent for the fourth straight policy meeting. The repo rate is the rate at which the central bank lends to commercial banks. The Reserve Bank of India kept its key rates unchanged once again as expected, citing upside risks to medium-term inflation target. The decision announced Tuesday meant that the repo rate was left unchanged at 8.00 percent for the fourth straight policy meeting. The repo rate is the rate at which the central bank lends to commercial banks.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.